MedTrace Logo

Radiofrequency Ablation for Warthin's Tumor

NCT05078541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-02-08

No results posted yet for this study

Summary

This study is a safety and feasibility study to determine if ultrasound guided radiofrequency ablation of parotid Warthin's tumor under local anesthesia is a safe and effective procedure compared to Parotidectomy while using less resources.

Conditions

  • Radiofrequency Ablation

Interventions

PROCEDURE

Ultrasound-guided Radiofrequency Ablation of Parotid Warthin's Tumor

The Procedure 1. Injection of local subcutaneous and pericapsular anaesthesia 2. Needle radiofrequency ablation under ultrasound guidance 3. Patients should communicate with operating surgeon upon excessive heat or pain 4. The procedure usually lasts 30-45 minutes

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • David CM Yeung, MBChB · Chinese University of Hong Kong

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-20
Primary Completion
2022-12-15
Completion
2022-12-15

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05078541 on ClinicalTrials.gov